Katsura Hata

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

Faustino Torrico, Joaquím Gascón, Fabiana Barreira et al. · The Lancet Infectious Diseases · 2021 · 194 citations · Full text

<i>In Vitro</i> Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds

Mamiko Miyazaki, Takaaki Horii, Katsura Hata et al. · Antimicrobial Agents and Chemotherapy · 2011 · 192 citations · Full text

E1210, a New Broad-Spectrum Antifungal, Suppresses Candida albicans Hyphal Growth through Inhibition of Glycosylphosphatidylinositol Biosynthesis

Naoaki Watanabe, Mamiko Miyazaki, Takaaki Horii et al. · Antimicrobial Agents and Chemotherapy · 2011 · 164 citations · Full text

Microbial Pathogens, Fungal Cell Biology, Glycobiology +16

Efficacy of Oral E1210, a New Broad-Spectrum Antifungal with a Novel Mechanism of Action, in Murine Models of Candidiasis, Aspergillosis, and Fusariosis

Katsura Hata, Takaaki Horii, Mamiko Miyazaki et al. · Antimicrobial Agents and Chemotherapy · 2011 · 140 citations · Full text

Oral E1210, Antifungal Agent, Allergy +12

GWT1 Gene Is Required for Inositol Acylation of Glycosylphosphatidylinositol Anchors in Yeast

Mariko Umemura, Michiyo Okamoto, Ken-ichi Nakayama et al. · Journal of Biological Chemistry · 2003 · 126 citations · Full text